当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202023
编号:13817475
外周血淋巴细胞/单核细胞比值对接受新药治疗的多发性骨髓瘤预后价值的研究(3)
http://www.100md.com 2020年8月15日 《中国医药导报》 202023
     [5] Cho H,Yoon DH,Lee JB,et al. Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy [J]. Am J Hematol,2017,92(12):1280-1286.

    [6] Zhang Y,Chen XL,Chen WM,et al. Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma [J]. Biomed Res Int ......
上一页1 2 3 4下一页

您现在查看是摘要页,全文长 2570 字符